State Street’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.1M Buy
7,997,153
+1,191,346
+18% +$4.34M ﹤0.01% 1975
2025
Q1
$13.1M Buy
6,805,807
+501,109
+8% +$962K ﹤0.01% 2360
2024
Q4
$12M Buy
6,304,698
+2,874,171
+84% +$5.46M ﹤0.01% 2523
2024
Q3
$4.53M Buy
3,430,527
+683,287
+25% +$902K ﹤0.01% 3010
2024
Q2
$2.8M Buy
2,747,240
+2,096,890
+322% +$2.14M ﹤0.01% 3179
2024
Q1
$1.19M Buy
650,350
+39,800
+7% +$72.8K ﹤0.01% 3426
2023
Q4
$757K Sell
610,550
-45,900
-7% -$56.9K ﹤0.01% 3541
2023
Q3
$748K Buy
656,450
+30,400
+5% +$34.7K ﹤0.01% 3594
2023
Q2
$573K Sell
626,050
-66,786
-10% -$61.1K ﹤0.01% 3659
2023
Q1
$388K Buy
692,836
+120,900
+21% +$67.8K ﹤0.01% 3832
2022
Q4
$330K Hold
571,936
﹤0.01% 3913
2022
Q3
$181K Sell
571,936
-1,940
-0.3% -$614 ﹤0.01% 4194
2022
Q2
$203K Sell
573,876
-10,914,348
-95% -$3.86M ﹤0.01% 4189
2022
Q1
$8.25M Sell
11,488,224
-255,237
-2% -$183K ﹤0.01% 2925
2021
Q4
$26.5M Sell
11,743,461
-4,112,967
-26% -$9.3M ﹤0.01% 2256
2021
Q3
$45.7M Buy
15,856,428
+1,849,791
+13% +$5.33M ﹤0.01% 1874
2021
Q2
$53.1M Sell
14,006,637
-3,037,539
-18% -$11.5M ﹤0.01% 1797
2021
Q1
$57.7M Sell
17,044,176
-5,432,358
-24% -$18.4M ﹤0.01% 1634
2020
Q4
$62.9M Buy
22,476,534
+7,136,063
+47% +$20M ﹤0.01% 1494
2020
Q3
$38.5M Buy
15,340,471
+10,328,433
+206% +$25.9M ﹤0.01% 1637
2020
Q2
$68.1M Buy
5,012,038
+1,595,108
+47% +$21.7M ﹤0.01% 1235
2020
Q1
$25.9M Sell
3,416,930
-25,066
-0.7% -$190K ﹤0.01% 1680
2019
Q4
$21.8M Sell
3,441,996
-203,661
-6% -$1.29M ﹤0.01% 2082
2019
Q3
$14.3M Sell
3,645,657
-2,153,025
-37% -$8.44M ﹤0.01% 2284
2019
Q2
$28.1M Buy
5,798,682
+2,416,715
+71% +$11.7M ﹤0.01% 1880
2019
Q1
$27.7M Buy
3,381,967
+744,121
+28% +$6.09M ﹤0.01% 1835
2018
Q4
$14.6M Buy
2,637,846
+356,704
+16% +$1.97M ﹤0.01% 2205
2018
Q3
$20.1M Buy
2,281,142
+350,738
+18% +$3.1M ﹤0.01% 2178
2018
Q2
$19.3M Buy
1,930,404
+430,191
+29% +$4.29M ﹤0.01% 2154
2018
Q1
$14.3M Buy
1,500,213
+13,974
+0.9% +$133K ﹤0.01% 2274
2017
Q4
$22.1M Buy
1,486,239
+197,353
+15% +$2.93M ﹤0.01% 1981
2017
Q3
$25.4M Buy
1,288,886
+341,998
+36% +$6.73M ﹤0.01% 1858
2017
Q2
$13.6M Buy
946,888
+399,160
+73% +$5.73M ﹤0.01% 2240
2017
Q1
$5.04M Buy
547,728
+16,147
+3% +$149K ﹤0.01% 2689
2016
Q4
$5.53M Buy
531,581
+17,817
+3% +$185K ﹤0.01% 2641
2016
Q3
$4.65M Buy
513,764
+27,431
+6% +$248K ﹤0.01% 2600
2016
Q2
$3.63M Buy
486,333
+63,562
+15% +$475K ﹤0.01% 2790
2016
Q1
$3.81M Buy
422,771
+118,561
+39% +$1.07M ﹤0.01% 2690
2015
Q4
$3.93M Buy
304,210
+27,072
+10% +$350K ﹤0.01% 2670
2015
Q3
$2.68M Buy
277,138
+46,028
+20% +$445K ﹤0.01% 2862
2015
Q2
$2.38M Buy
231,110
+127,816
+124% +$1.32M ﹤0.01% 2994
2015
Q1
$1.15M Buy
103,294
+4,678
+5% +$51.9K ﹤0.01% 3203
2014
Q4
$1.14M Buy
98,616
+23,407
+31% +$272K ﹤0.01% 3228
2014
Q3
$1.67M Buy
75,209
+2,227
+3% +$49.3K ﹤0.01% 3090
2014
Q2
$2.03M Buy
+72,982
New +$2.03M ﹤0.01% 3064